HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Huang Selected Research

AEOL 10150

1/2018Neuroprotective Effects of AEOL10150 in a Rat Organophosphate Model.
12/2016From the Cover: Catalytic Antioxidant Rescue of Inhaled Sulfur Mustard Toxicity.
5/2010Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide.
2/2007Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Huang Research Topics

Disease

162Neoplasms (Cancer)
09/2022 - 01/2003
53Infections
06/2022 - 10/2005
46Inflammation (Inflammations)
03/2022 - 09/2003
23Lung Neoplasms (Lung Cancer)
01/2022 - 08/2013
23Heart Failure
01/2021 - 01/2006
17Breast Neoplasms (Breast Cancer)
08/2022 - 09/2004
16Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 01/2011
16Neoplasm Metastasis (Metastasis)
01/2022 - 03/2007
15Fibrosis (Cirrhosis)
03/2022 - 08/2008
15Carcinoma (Carcinomatosis)
01/2021 - 01/2003
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2014
13Sepsis (Septicemia)
10/2022 - 07/2010
12Hypertension (High Blood Pressure)
01/2021 - 06/2006
11Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2013
10Hypoxia (Hypoxemia)
03/2022 - 02/2007
10Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 03/2004
10Body Weight (Weight, Body)
12/2021 - 08/2013
10Necrosis
08/2020 - 03/2007
9Hemorrhage
01/2022 - 10/2009
8Adenocarcinoma of Lung
06/2022 - 11/2017
8Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022 - 11/2019
8Brain Neoplasms (Brain Tumor)
01/2022 - 03/2015
8Wounds and Injuries (Trauma)
01/2022 - 11/2014
8Obesity
01/2022 - 04/2011
8Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2014
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2021 - 05/2012
8Cognitive Dysfunction
02/2021 - 01/2016
8Myocardial Infarction
01/2021 - 01/2012
8Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 05/2002
7Stroke (Strokes)
07/2022 - 09/2013
7Glioma (Gliomas)
01/2022 - 03/2012
7Acute Lung Injury
12/2021 - 01/2016
7Insulin Resistance
12/2021 - 10/2004
7Uterine Neoplasms (Uterine Cancer)
10/2021 - 04/2014
7Cardiomyopathies (Cardiomyopathy)
04/2021 - 10/2007
7Rheumatoid Arthritis
01/2021 - 01/2006
6Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 04/2007
6Chest Pain (Chest Pains)
01/2022 - 01/2018
6Atrial Fibrillation
01/2021 - 07/2010
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2012
6Pathologic Constriction (Stenosis)
01/2019 - 08/2005
5Cardiotoxicity
07/2022 - 01/2012
5Reperfusion Injury
05/2022 - 01/2012
5COVID-19
02/2022 - 11/2020
5Idiopathic Pulmonary Fibrosis
01/2022 - 11/2019
5Pulmonary Embolism
01/2022 - 05/2015
5Medulloblastoma
01/2022 - 04/2014
5Pneumonia (Pneumonitis)
12/2021 - 02/2011

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2006
42Pharmaceutical PreparationsIBA
02/2022 - 03/2002
38Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2007
27CytokinesIBA
03/2022 - 11/2002
25Biological ProductsIBA
01/2022 - 07/2004
21MicroRNAs (MicroRNA)IBA
06/2022 - 01/2011
16LipopolysaccharidesIBA
04/2022 - 12/2015
12RNA (Ribonucleic Acid)IBA
06/2022 - 05/2008
12AntioxidantsIBA
01/2022 - 02/2007
11Messenger RNA (mRNA)IBA
12/2021 - 03/2014
11Phosphotransferases (Kinase)IBA
11/2021 - 08/2012
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2009
10Glucose (Dextrose)FDA LinkGeneric
12/2021 - 06/2006
10Interleukin-6 (Interleukin 6)IBA
12/2021 - 11/2002
10Cisplatin (Platino)FDA LinkGeneric
12/2020 - 03/2004
9Transcription Factors (Transcription Factor)IBA
01/2022 - 09/2003
9Circular RNAIBA
01/2022 - 01/2018
8Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 12/2006
8Insulin (Novolin)FDA Link
12/2021 - 01/2003
8Therapeutic UsesIBA
12/2021 - 04/2007
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2006
7Paclitaxel (Taxol)FDA LinkGeneric
10/2021 - 08/2012
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 12/2010
7Small Interfering RNA (siRNA)IBA
03/2018 - 11/2005
7pro-brain natriuretic peptide (1-76)IBA
03/2018 - 01/2006
6Doxorubicin (Adriamycin)FDA LinkGeneric
07/2022 - 10/2011
6NucleotidesIBA
02/2022 - 05/2012
6Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 04/2011
6CalciumIBA
01/2022 - 11/2002
6TroponinIBA
01/2022 - 01/2018
6LipidsIBA
01/2021 - 06/2006
6AntibodiesIBA
01/2021 - 07/2005
6CateninsIBA
09/2020 - 01/2014
6LigandsIBA
01/2018 - 09/2011
6Histones (Histone)IBA
04/2017 - 09/2007
5VaccinesIBA
05/2022 - 03/2010
5Histone Deacetylases (Histone Deacetylase)IBA
03/2022 - 09/2007
5Silicon Dioxide (Silica)FDA LinkGeneric
02/2022 - 01/2018
5GoldIBA
01/2022 - 09/2015
5EnzymesIBA
01/2022 - 07/2010
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 05/2014
5Long Noncoding RNAIBA
12/2021 - 04/2020
5Blood Glucose (Blood Sugar)IBA
12/2021 - 04/2011
5Dasatinib (BMS 354825)FDA Link
10/2021 - 08/2011

Therapy/Procedure

88Therapeutics
09/2022 - 03/2002
24Drug Therapy (Chemotherapy)
01/2022 - 06/2006
18Radiotherapy
01/2022 - 06/2013
9Heart Transplantation (Grafting, Heart)
01/2016 - 11/2006
8Length of Stay
05/2022 - 12/2006
7Transplantation
03/2022 - 11/2006
6Immunotherapy
11/2021 - 01/2020
5Aftercare (After-Treatment)
06/2022 - 03/2007